These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 10613832)

  • 21. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
    Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
    Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knockdown of HURP inhibits the proliferation of hepacellular carcinoma cells via downregulation of gankyrin and accumulation of p53.
    Kuo TC; Chang PY; Huang SF; Chou CK; Chao CC
    Biochem Pharmacol; 2012 Mar; 83(6):758-68. PubMed ID: 22230478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19 S proteasomal ATPase regulator, and the tumor suppressors Rb and p53.
    Krzywda S; Brzozowski AM; Higashitsuji H; Fujita J; Welchman R; Dawson S; Mayer RJ; Wilkinson AJ
    J Biol Chem; 2004 Jan; 279(2):1541-5. PubMed ID: 14573599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inducible liver-specific overexpression of gankyrin in zebrafish results in spontaneous intrahepatic cholangiocarcinoma and hepatocellular carcinoma formation.
    Huang SJ; Cheng CL; Chen JR; Gong HY; Liu W; Wu JL
    Biochem Biophys Res Commun; 2017 Aug; 490(3):1052-1058. PubMed ID: 28668389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovering a potent small molecule inhibitor for gankyrin using de novo drug design approach.
    Thakur PK; Hassan I
    Int J Comput Biol Drug Des; 2011; 4(4):373-86. PubMed ID: 22199037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The up-regulation of proteasome subunits and lysosomal proteases in hepatocellular carcinomas of the HBx gene knockin transgenic mice.
    Cui F; Wang Y; Wang J; Wei K; Hu J; Liu F; Wang H; Zhao X; Zhang X; Yang X
    Proteomics; 2006 Jan; 6(2):498-504. PubMed ID: 16317774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
    Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B x antigen up-regulates vascular endothelial growth factor receptor 3 in hepatocarcinogenesis.
    Lian Z; Liu J; Wu M; Wang HY; Arbuthnot P; Kew M; Feitelson MA
    Hepatology; 2007 Jun; 45(6):1390-9. PubMed ID: 17539024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma.
    Narla G; Kremer-Tal S; Matsumoto N; Zhao X; Yao S; Kelley K; Tarocchi M; Friedman SL
    Oncogene; 2007 Jun; 26(30):4428-34. PubMed ID: 17297474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Influence of p16 gene on the biological behavior of human hepatocellular carcinoma].
    Huang JZ; Xia SS; Ye QF; Jiang HY
    Ai Zheng; 2003 Jan; 22(1):46-9. PubMed ID: 12561435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of tumorigenicity of rat liver tumor cells by human chromosome 13: evidence against the involvement of pRb and BRCA2.
    Rider MA; Butz GM; Ricketts SL; Newberry ST; Grisham JW; Coleman WB
    Int J Oncol; 2002 Feb; 20(2):235-45. PubMed ID: 11788883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
    Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
    Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K; Hashimoto T; Kitamura N; Tanaka T
    Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human S15a expression is upregulated by hepatitis B virus X protein.
    Lian Z; Liu J; Li L; Li X; Tufan NL; Wu MC; Wang HY; Arbuthnot P; Kew M; Feitelson MA
    Mol Carcinog; 2004 May; 40(1):34-46. PubMed ID: 15108328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knock-down of hepatitis B virus X protein reduces the tumorigenicity of hepatocellular carcinoma cells.
    Chan DW; Ng IO
    J Pathol; 2006 Feb; 208(3):372-80. PubMed ID: 16353167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of p28GANK and its correlation with RB in human hepatocellular carcinoma.
    Tan L; Fu XY; Liu SQ; Li HH; Hong Y; Wu MC; Wang HY
    Liver Int; 2005 Jun; 25(3):667-76. PubMed ID: 15910504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway.
    Zhao X; Fu J; Xu A; Yu L; Zhu J; Dai R; Su B; Luo T; Li N; Qin W; Wang B; Jiang J; Li S; Chen Y; Wang H
    Cell Death Dis; 2015 May; 6(5):e1751. PubMed ID: 25950481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel insights into the INK4-CDK4/6-Rb pathway: counter action of gankyrin against INK4 proteins regulates the CDK4-mediated phosphorylation of Rb.
    Li J; Tsai MD
    Biochemistry; 2002 Mar; 41(12):3977-83. PubMed ID: 11900540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of p28GANK in rat oval cells activation and proliferation.
    Shan YF; Zhou WP; Fu XY; Yan HX; Yang W; Liu SQ; Cao HF; Kang B; Wu MC; Wang HY
    Liver Int; 2006 Mar; 26(2):240-7. PubMed ID: 16448463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.